Yet in places where, because of a better diet or for other reasons, high cholesterol is less common, APOE4 is either less of a risk factor for Alzheimers (like in East-Asians) or not at all (like in Africas Bushmen) (Notkola et al., 1998)
Saxenda: Overview The Bottom Line At higher doses, Zepbound produces roughly 2-3x more weight loss than Saxenda in clinical trials (results vary by dose and diabetes statuscloser to 1.5-2x in some populations)
Physical activity levels also influence reported outcomes, with both highly active individuals and sedentary people reporting benefits, though for different reasons
Without affordable medications for weight loss and AI-powered behaviour change, we risk bankrupting the US healthcare system. The market opportunity for GLP-1s in the US continues to grow, with expectations that it exceeds US$100 billion with 30 million total users by 2030
Variety of great tasting flavors